Supplier
Christopher M Geronsin INC.
Christopher M Geronsin INC. was paid $199K by Medicaid between Jan 2018 and Dec 2024, across 11 billing codes. Its largest line is 99607, — 39% of everything it billed.
33Billing provider infoCHRISTOPHER M GERONSIN INC.
SAINT LOUIS, MO 63121
SAINT LOUIS, MO 63121
33aNPI1467488056assigned 06/24/2006
33bProvider typeCommunity/Retail Pharmacy
28Total paid$199K
24GClaims7,653
24DCodes billed11
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Retail Pharmacy providers in Missouri
Rank by total paid#4 of 47
Median peer was paid$3K
This provider vs. median68×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,148 | $9K | |
| 2019 | 1,006 | $7K | |
| 2020 | 852 | $3K | |
| 2021 | 604 | $3K | |
| 2022 | 396 | $2K | |
| 2023 | 146 | $14K | |
| 2024incomplete | 3,501 | $160K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99607 | 39% | 1,682 | 1,656 | $78K | |
| 99606 | 27% | 1,446 | 1,424 | $53K | |
| T2028 | Specialized supply, not otherwise specified, waiver | 14% | 316 | 211 | $28K |
| 99605 | 8.8% | 238 | 234 | $17K | |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 5.4% | 1,184 | 1,140 | $11K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 2.7% | 1,233 | 1,204 | $5K |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | 1.7% | 82 | 68 | $3K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 846 | 772 | $2K |
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 14 | 13 | $1K |
| A4259 | Lancets, per box of 100 | <1% | 570 | 551 | $224.36 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 42 | 36 | $91.06 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGERONSIN, CHRISTOPHER (PRESIDENT)